|
PDE12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.08500000095546E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.38089999937685E-08 |
| Normal-vs-Stage2 |
2.595100E-03 |
| Normal-vs-Stage3 |
1.960030E-04 |
| Normal-vs-Stage4 |
1.65819999997652E-06 |
| Stage1-vs-Stage2 |
8.766200E-01 |
| Stage1-vs-Stage3 |
9.000200E-01 |
| Stage1-vs-Stage4 |
1.359160E-01 |
| Stage2-vs-Stage3 |
9.690800E-01 |
| Stage2-vs-Stage4 |
2.497400E-01 |
| Stage3-vs-Stage4 |
2.994600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.05260000505103E-09 |
| Normal-vs-AfricanAmerican |
1.85259999996301E-06 |
| Normal-vs-Asian |
4.304100E-03 |
| Caucasian-vs-AfricanAmerican |
6.431800E-01 |
| Caucasian-vs-Asian |
9.010000E-01 |
| AfricanAmerican-vs-Asian |
7.840800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.41039974038893E-10 |
| Normal-vs-Female |
4.635700E-03 |
| Male-vs-Female |
4.817900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.19960000000286E-05 |
| Normal-vs-Extreme_Weight |
4.18870049756492E-10 |
| Normal-vs-Obese |
1.07299999996258E-06 |
| Normal-vs-Extreme_Obese |
4.548000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.532200E-01 |
| Normal_Weight-vs-Obese |
9.446200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.832600E-01 |
| Extreme_Weight-vs-Obese |
1.453650E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.937600E-01 |
| Obese-vs-Extreme_Obese |
7.732200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.001150E-04 |
| Normal-vs-Age(41-60Yrs) |
5.95639999545483E-08 |
| Normal-vs-Age(61-80Yrs) |
9.82899994728115E-09 |
| Normal-vs-Age(81-100Yrs) |
4.21990000000205E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.113200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.475800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.565000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.256400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.609600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.042600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.35810004856063E-09 |
| Normal-VS-Type2 PRCC |
6.13979999999348E-05 |
| Normal-VS-KIRP CIMP |
7.302800E-03 |
| Normal-VS-Unclassified PRCC |
3.57120000005207E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.911600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.572000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.613200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.075400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.508400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.801000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.87949997179737E-09 |
| Normal-vs-N1 |
2.74460000004861E-06 |
| Normal-vs-N2 |
8.816900E-04 |
| N0-vs-N1 |
3.602000E-01 |
| N0-vs-N2 |
6.466000E-01 |
| N1-vs-N2 |
3.752600E-01 |
|
|
